OpenPayments Data #3: Subsidiary Filings Prt. 2
First, some context: The requirement for direct-to-doctor (D2D) marketing transparency was enacted by Physician Payment Sunshine Act as part of ACA reforms in 2010. The call for transparency was initiated in response to concerns that D2D marketing practices by pharmaceutical & medical device companies may exert on undue influence on physician prescription practices. These concerns … Continue reading OpenPayments Data #3: Subsidiary Filings Prt. 2
MODEX 